Every story in this section, newest first — page 265 of 373.
Canadian Natural Resources (NYSE:CNQ) reported record-breaking operational and financial results for fiscal year 2025, reaching a long-awaited net debt target that paves the way for a massive increase in shareholder returns.
Autohome (NYSE:ATHM), China’s leading online destination for automobile consumers, reported a decline in fourth-quarter and full-year earnings for 2025, even as its nascent online marketplace showed signs of long-term momentum.
The Business Council of Australia and the Business Council of Canada have signed a pivotal memorandum of understanding to accelerate trade and investment between the two nations.
Rumble (NASDAQ:RUM) reported fourth-quarter results on Thursday that featured a historic revenue milestone and a narrowed net loss, as the "freedom-first" platform continues its transformation into an artificial intelligence and cloud infrastructure provider.
Marvell Technology (NASDAQ:MRVL) reported record-breaking fourth-quarter and full-year results for fiscal 2026 on Thursday, bolstered by an unprecedented wave of capital investment in artificial intelligence and data center infrastructure.
Gevo (NASDAQ:GEVO) reported fourth-quarter financial results on Thursday that highlighted a significant operational turnaround, driven by the successful integration of its Red Trail Energy acquisition and record ethanol production.
Tango Therapeutics (NASDAQ:TNGX) reported fourth-quarter financial results on Thursday that surpassed Wall Street’s bottom-line expectations, supported by a significant extension of its capital reserves.
Scorpio Tankers (NYSE:STNG) announced on Thursday a series of agreements to sell three aging product tankers and secure multi-year charters for two others, marking a continued push to capitalize on high asset values while locking in steady cash flows.
Brilliant Earth Group (NASDAQ:BRLT) reported record-breaking fourth-quarter revenue on Thursday, though the results failed to meet Wall Street’s profitability expectations.
Kura Oncology (NASDAQ:KURA) reported fourth-quarter and full-year 2025 financial results on Thursday, marked by the inaugural commercial sales of its newly approved AML treatment, KOMZIFTI.
CPI Card Group (NASDAQ:PMTS) reported fourth-quarter results on Thursday that surpassed Wall Street’s revenue expectations, fueled by the strategic integration of Arroweye and a surge in contactless card demand.
Ranger Energy Services (NYSE:RNGR) reported fourth-quarter and full-year 2025 results on Thursday, highlighting a sequential recovery in activity and robust free cash flow generation.
Distribution Solutions Group (NASDAQ:DSGR) reported fourth-quarter financial results on Thursday that fell short of Wall Street’s expectations, as industrial sector headwinds pressured both top-line growth and operating margins.
FTC Solar (NASDAQ:FTCI) reported fourth-quarter results on Thursday that surpassed analyst bottom-line expectations, even as the company issued a cautious outlook for the start of 2026.
Global Ship Lease (NYSE:GSL) reported a substantial increase in fourth-quarter earnings on Thursday, bolstered by high fleet utilization and strategic charter renewals.
Immatics (NASDAQ:IMTX), a Tübingen, Germany-based clinical-stage biopharmaceutical company developing T cell receptor (TCR)-based immunotherapies for the treatment of solid tumors, on Thursday reported a net loss of $41.6 million for its fourth quarter ended December 31, 2025.
Lexicon Pharmaceuticals (NASDAQ:LXRX) reported fourth-quarter financial results on Thursday that exceeded Wall Street expectations, driven by reduced operating expenses and licensing revenue.
Regenxbio (NASDAQ:RGNX) shares faced pressure Thursday after the biotechnology company reported fourth-quarter financial results that trailed Wall Street expectations on both the top and bottom lines.
MediWound (NASDAQ:MDWD), a biopharmaceutical developer focused on enzymatic therapeutics for tissue repair, reported fourth-quarter losses that were narrower than analysts had anticipated.
Olaplex Holdings (NASDAQ:OLPX) shares declined on Thursday after the company provided a cautious financial outlook for 2026, overshadowing a fourth quarter that saw a modest return to top-line growth.
Bioventus (NASDAQ:BVS) reported a return to profitability for the full year 2025, supported by a strong fourth-quarter performance that saw organic revenue accelerate across its core healing therapies.
John Wiley & Sons (NYSE:WLY) reported third-quarter results on Thursday that underscored the company's ongoing efforts to streamline operations and focus on its high-growth research publishing business.
Victoria’s Secret (NYSE:VSCO) reported fourth-quarter and full-year 2025 results on March 5, 2026, that surpassed both internal guidance and Wall Street estimates.
Burlington Stores (NYSE:BURL) reported a robust fourth-quarter performance that exceeded internal expectations, driven by strong customer traffic and a significant expansion in profit margins.
